Market Overview:
The global real-time polymerase chain reaction (PCR) systems market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for PCR systems in various applications such as gene expression analysis, genotyping, GMO detection, and others. In addition, the growing demand for personalized medicine and rising prevalence of target diseases are also contributing to the growth of this market. Based on type, the global real-time PCR systems market can be segmented into non-specific detection and specific detection. The specific detection segment is further subsegmented into singleplex PCR and multiplex PCR. Based on application, the global real-time PCR systems market can be divided into gene expression analysis, genotyping, GMO detection,, and others (drug discovery & development). Geographically speaking,, North America dominates the global real-time PCRsystemsmarket due to technological advancements in this region coupled with increasing R&D spending by pharmaceutical companies.
Product Definition:
Real-time polymerase chain reaction, or RT-PCR, is a molecular biology technique used to amplify specific DNA sequences. The amplified DNA can then be detected and quantified using various techniques such as fluorescence spectroscopy. The use of RT-PCR has revolutionized the study of gene expression by allowing the detection and quantification of mRNA levels in real time. Additionally, RT-PCR can be used for genotyping and forensic analysis.
Non-Specific Detection:
Non-specific detection, also known as the enzyme-linked immunosorbent assay (ELISA) is a technique used for the detection of an analyte in biological fluids. It is one of the most important and widely applied techniques in clinical laboratories. The ELISA technique has been evolving over decades with constant improvements made to its sensitivity, specificity, and ease of use.
Specific Detection:
Specific detection is a method used to measure the amount of a particular nucleic acid sequence in a sample. It helps in monitoring real time polymerase chain reaction (PCR) systems. The method is based on the comparison of two samples, one of which contains known amount of target sequence while other serves as an internal standard for quantification.
The global specific detection.
Application Insights:
The gene expression analysis segment dominated the global real time polymerase chain reaction systems market in terms of revenue in 2017. This is attributed to the rising adoption of RPA for monitoring and profiling gene expression during various stages of plant, animal, and cell development. Gene expression analysis provides a detailed look at the dynamic behavior of genes under different conditions which includes identification and characterization of new genes as well as their regulation by other genes. It also detects changes in gene function due to mutations or abnormalities present at a genomic level.
Rising demand for rapid detection methodologies that provide results within minutes instead hours has been driving segment growth across all regions over recent years. The presence of stringent government regulations pertaining to food safety across various countries has further driven demand from the genetic analysis segment owing to increased focus on detecting novel pathogens rapidly through RPA techniques such as next-generation DNA sequencing (NGS).
Regional Analysis:
North America dominated the global real time polymerase chain reaction systems market in 2017. This is due to presence of well-established healthcare infrastructure, high disposable income, and increasing demand for rapid diagnostic tests. Moreover, introduction of technologically advanced products has increased the penetration of R&D-based services in this region.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising number of research initiatives by pharmaceutical companies and academic institutions for developing novel molecular diagnostics techniques that are cost-effective and offer higher specificity/ sensitivity as compared to conventional methods used in clinical laboratories. Furthermore, growing awareness regarding cancer detection among people will drive regional growth during the forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests
- Rising prevalence of infectious diseases
- Technological advancements in PCR systems
- Growing demand for personalized medicine
- Increasing funding for research and development in the field of molecular diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Real Time Polymerase Chain Reaction Systems Market Research Report
By Type
Non-Specific Detection, Specific Detection
By Application
Gene Expression Analysis, Genotyping, GMO Detection, Others
By Companies
GeneCopoeia, PCR Biosystems, OriGene Technologies, BioFire Defense, Genesystem, GenePharma, Elveflow, Quidel, Biolabmix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Real Time Polymerase Chain Reaction Systems Market Report Segments:
The global Real Time Polymerase Chain Reaction Systems market is segmented on the basis of:
Types
Non-Specific Detection, Specific Detection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gene Expression Analysis, Genotyping, GMO Detection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GeneCopoeia
- PCR Biosystems
- OriGene Technologies
- BioFire Defense
- Genesystem
- GenePharma
- Elveflow
- Quidel
- Biolabmix
Highlights of The Real Time Polymerase Chain Reaction Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-Specific Detection
- Specific Detection
- By Application:
- Gene Expression Analysis
- Genotyping
- GMO Detection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Real Time Polymerase Chain Reaction Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Real-time polymerase chain reaction (RT-PCR) is a technique used to rapidly and accurately measure the amount of DNA or RNA present in a sample. RT-PCR is often used to determine the presence or absence of specific genes, as well as the quantity of those genes.
Some of the major players in the real time polymerase chain reaction systems market are GeneCopoeia, PCR Biosystems, OriGene Technologies, BioFire Defense, Genesystem, GenePharma, Elveflow, Quidel, Biolabmix.
The real time polymerase chain reaction systems market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Real Time Polymerase Chain Reaction Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Real Time Polymerase Chain Reaction Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Real Time Polymerase Chain Reaction Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Real Time Polymerase Chain Reaction Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Real Time Polymerase Chain Reaction Systems Market Size & Forecast, 2018-2028
4.5.1 Real Time Polymerase Chain Reaction Systems Market Size and Y-o-Y Growth
4.5.2 Real Time Polymerase Chain Reaction Systems Market Absolute $ Opportunity
Chapter 5 Global Real Time Polymerase Chain Reaction Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Real Time Polymerase Chain Reaction Systems Market Size Forecast by Type
5.2.1 Non-Specific Detection
5.2.2 Specific Detection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Real Time Polymerase Chain Reaction Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Real Time Polymerase Chain Reaction Systems Market Size Forecast by Applications
6.2.1 Gene Expression Analysis
6.2.2 Genotyping
6.2.3 GMO Detection
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Real Time Polymerase Chain Reaction Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Real Time Polymerase Chain Reaction Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Real Time Polymerase Chain Reaction Systems Analysis and Forecast
9.1 Introduction
9.2 North America Real Time Polymerase Chain Reaction Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Real Time Polymerase Chain Reaction Systems Market Size Forecast by Type
9.6.1 Non-Specific Detection
9.6.2 Specific Detection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Real Time Polymerase Chain Reaction Systems Market Size Forecast by Applications
9.10.1 Gene Expression Analysis
9.10.2 Genotyping
9.10.3 GMO Detection
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Real Time Polymerase Chain Reaction Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Real Time Polymerase Chain Reaction Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Real Time Polymerase Chain Reaction Systems Market Size Forecast by Type
10.6.1 Non-Specific Detection
10.6.2 Specific Detection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Real Time Polymerase Chain Reaction Systems Market Size Forecast by Applications
10.10.1 Gene Expression Analysis
10.10.2 Genotyping
10.10.3 GMO Detection
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Real Time Polymerase Chain Reaction Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Real Time Polymerase Chain Reaction Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Real Time Polymerase Chain Reaction Systems Market Size Forecast by Type
11.6.1 Non-Specific Detection
11.6.2 Specific Detection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Real Time Polymerase Chain Reaction Systems Market Size Forecast by Applications
11.10.1 Gene Expression Analysis
11.10.2 Genotyping
11.10.3 GMO Detection
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Real Time Polymerase Chain Reaction Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Real Time Polymerase Chain Reaction Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Real Time Polymerase Chain Reaction Systems Market Size Forecast by Type
12.6.1 Non-Specific Detection
12.6.2 Specific Detection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Real Time Polymerase Chain Reaction Systems Market Size Forecast by Applications
12.10.1 Gene Expression Analysis
12.10.2 Genotyping
12.10.3 GMO Detection
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Real Time Polymerase Chain Reaction Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Real Time Polymerase Chain Reaction Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Real Time Polymerase Chain Reaction Systems Market Size Forecast by Type
13.6.1 Non-Specific Detection
13.6.2 Specific Detection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Real Time Polymerase Chain Reaction Systems Market Size Forecast by Applications
13.10.1 Gene Expression Analysis
13.10.2 Genotyping
13.10.3 GMO Detection
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Real Time Polymerase Chain Reaction Systems Market: Competitive Dashboard
14.2 Global Real Time Polymerase Chain Reaction Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GeneCopoeia
14.3.2 PCR Biosystems
14.3.3 OriGene Technologies
14.3.4 BioFire Defense
14.3.5 Genesystem
14.3.6 GenePharma
14.3.7 Elveflow
14.3.8 Quidel
14.3.9 Biolabmix
